The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care

Part of paid clinical trials in Flint, Michigan.

Sponsor
National Minority Quality Forum
Study ID
NCT07461493
Status
Recruiting
Apply to this trial

Conditions

  • Cancer
  • Cancer Comorbidities

Eligibility Criteria

Sex
ALL
Age
35 Years - N/A
Healthy Volunteers
Accepted

Study Details

The goal of this observational study is to establish a patient registry and a biorepository (sample collection and storage) to investigate health disparities, access, and barriers to cancer screening and early detection technologies. The registry and biorepository will serve as a resource to support Cancer Early Detection (CED) screenings and future research focused on communities at increased risk for cancer. The study seeks to address: •Barriers and disparities in cancer prevention, screening, and treatment, particularly in historically underrepresented populations. Participants will: * Attend a minimum of five clinic visits over a five-year period for scheduled annual assessments while actively enrolled in the study. * Complete questionnaires at each visit that collect information on their medical history, cancer history, and family cancer history. * Allow relevant health information from their electronic health records (EHR) to be collected and reviewed. * Provide blood, saliva, and stool samples for research purposes. * Enter a long-term follow-up period for an additional five years.

Key Dates

Start date
Mar 11, 2025
Status verified
Apr 2026
Primary completion
Mar 31, 2034
Completion
Mar 31, 2039

Study Design

Enrollment
100,000 participants (estimated)

Arms

  • Arm: Average Cancer Risk
    Participants who are 35 years of age or older and have no identified cancer risk factors will be classified into the average-risk cohort.
  • Arm: High Cancer Risk
    Participants who are 35 years of age or older and have one or more cancer risk factors will be classified into the high-risk cohort.

Primary Outcome Measure

Establish a patient registry [ Time Frame: From enrollment to the end of follow up at 10 years. ]

Locations (2)

FacilityCityStateZIPSite coordinators
Life in 3D Health ServicesFlintMichigan48507
Denika Dalton, DNP-C
[email protected]
810-780-4189
Rockefeller Oteng, MD (PRINCIPAL_INVESTIGATOR)
Denika Dalton, DNP-C (SUB_INVESTIGATOR)
Grace ClinicHoustonTexas77026
Sheila Young, FNP-BC
[email protected]
713-993-6000
Chi Si Choi, MD (PRINCIPAL_INVESTIGATOR)
Sheila Young, FNP-BC (SUB_INVESTIGATOR)

Find similar trials in Flint, MI

By research site
Life in 3D Health Services· Flint, MIGrace Clinic· Houston, TX

Related Studies